Lim KH - Search Results

1

Immunotherapy in gastrointestinal cancers.

Grierson P, Lim KH, Amin M. Grierson P, et al. Among authors: lim kh. J Gastrointest Oncol. 2017 Jun;8(3):474-484. doi: 10.21037/jgo.2017.05.01. J Gastrointest Oncol. 2017. PMID: 28736635 Free PMC article. Review.

2

Entering the molecular era of gastrointestinal oncology: current updates and challenges.

Wang-Gillam A, Lim KH. Wang-Gillam A, et al. Among authors: lim kh. J Gastrointest Oncol. 2017 Jun;8(3):377-378. doi: 10.21037/jgo.2017.05.02. J Gastrointest Oncol. 2017. PMID: 28736625 Free PMC article. No abstract available.

3

Molecular landscape and sub-classification of gastrointestinal cancers: a review of literature.

Fakhri B, Lim KH. Fakhri B, et al. Among authors: lim kh. J Gastrointest Oncol. 2017 Jun;8(3):379-386. doi: 10.21037/jgo.2016.11.01. J Gastrointest Oncol. 2017. PMID: 28736626 Free PMC article. Review.

4

Current biologics for treatment of biliary tract cancers.

Zhao DY, Lim KH. Zhao DY, et al. Among authors: lim kh. J Gastrointest Oncol. 2017 Jun;8(3):430-440. doi: 10.21037/jgo.2017.05.04. J Gastrointest Oncol. 2017. PMID: 28736630 Free PMC article. Review.

5

Pacritinib to inhibit JAK/STAT signaling in refractory metastatic colon and rectal cancer.

Regenbogen T, Chen L, Trinkaus K, Wang-Gillam A, Tan BR, Amin M, Pedersen KS, Park H, Suresh R, Lim KH, Ratchford E, Brown A, Lockhart AC. Regenbogen T, et al. Among authors: lim kh. J Gastrointest Oncol. 2017 Dec;8(6):985-989. doi: 10.21037/jgo.2017.08.16. J Gastrointest Oncol. 2017. PMID: 29299358 Free PMC article.

6

Distinct clinical and magnetic resonance features of metastatic hepatocellular carcinoma treated with pembrolizumab: A case report of late response after pseudoprogression.

Grierson P, Crites D, Ruzinova MB, Yano M, Lim KH. Grierson P, et al. Among authors: lim kh. Hepatol Commun. 2017 Dec 19;2(2):148-151. doi: 10.1002/hep4.1132. eCollection 2018 Feb. Hepatol Commun. 2017. PMID: 29404522 Free PMC article.

7

Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models.

Jiang H, Xu M, Li L, Grierson P, Dodhiawala P, Highkin M, Zhang D, Li Q, Wang-Gillam A, Lim KH. Jiang H, et al. Among authors: lim kh. Mol Cancer Ther. 2018 Oct;17(10):2144-2155. doi: 10.1158/1535-7163.MCT-17-1142. Epub 2018 Jul 31. Mol Cancer Ther. 2018. PMID: 30065098 Free PMC article.

8

IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in colorectal cancer.

Li Q, Chen Y, Zhang D, Grossman J, Li L, Khurana N, Jiang H, Grierson PM, Herndon J, DeNardo DG, Challen GA, Liu J, Ruzinova MB, Fields RC, Lim KH. Li Q, et al. Among authors: lim kh. JCI Insight. 2019 Oct 3;4(19):e130867. doi: 10.1172/jci.insight.130867. JCI Insight. 2019. PMID: 31527315 Free PMC article.

9

Phase Ib/II study combining tosedostat with capecitabine in patients with advanced pancreatic adenocarcinoma.

Grierson P, Teague A, Suresh R, Lim KH, Amin M, Pedersen K, Tan B, Huffman J, Boice N, Du L, Liu J, Lockhart AC, Wang-Gillam A. Grierson P, et al. Among authors: lim kh. J Gastrointest Oncol. 2020 Feb;11(1):61-67. doi: 10.21037/jgo.2019.11.06. J Gastrointest Oncol. 2020. PMID: 32175106 Free PMC article.

10

FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers: A Phase 2 Nonrandomized Clinical Trial.

Park H, Jin RU, Wang-Gillam A, Suresh R, Rigden C, Amin M, Tan BR, Pedersen KS, Lim KH, Trikalinos NA, Acharya A, Copsey ML, Navo KA, Morton AE, Gao F, Lockhart AC. Park H, et al. Among authors: lim kh. JAMA Oncol. 2020 Aug 1;6(8):1231-1240. doi: 10.1001/jamaoncol.2020.2020. JAMA Oncol. 2020. PMID: 32469386 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,088 results

Search Page

Filters